Introduction to the price and purchasing channels of a box of Dasatinib

Dasatinib is an oral tyrosine kinase inhibitor mainly used to treat hematological malignant diseases related to chromosomal abnormalities such as chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL). As a second-generation BCR-ABL inhibitor, dasatinib has shown good efficacy in patients who are resistant or intolerant to imatinib. At present, the drug has been officially launched in mainland China and has been included in the scope of medical insurance. However, due to the high price of the original drug, it is still a considerable financial burden.

In the domestic market, the common specifications of dasatinib are 20mg, 50mg, 70mg and 100mg, etc. The prices of different specifications and packaging are slightly different. Taking the specification of 100mg as an example, the price per box is about 6000 RMB, and the price may fluctuate in some areas. Although it can be partially reimbursed after being included in medical insurance, due to different medical insurance reimbursement ratios and payment policies in different provinces and cities, the final price paid by an individual may range from 1,000 yuan to 3,000 yuan. It is recommended that patients consult the pharmacy of their hospital to obtain the accurate post-reimbursement cost.

In addition to the domestic original version, patients can also choose foreign generic drugs as alternative treatment options. Currently, there are many manufacturers producing generic dasatinib drugs in the Indian generic drug market, such as well-known pharmaceutical companies such as Mylan (Mylan) and Natco (Natco). Taking the 100mg specifications produced by Natco and Mylan in India as an example, each box sells for about 500~600 yuan, which is far lower than the pricing of domestic original drugs. These generic drugs are basically the same as the original drugs in terms of active ingredients, dosage and efficacy, and have been recognized by clinical practice in many countries around the world.

If patients want to purchase Indian generic drugs, they can obtain them through formal third-party medical service agencies, cross-border pharmacies or overseas purchasing platforms. However, special attention must be paid to whether the source of the drug is legal, whether the channel is safe and reliable, and to ensure that the product is an authentic and effective version of a generic drug. Before trying to purchase drugs across the border, patients are advised to communicate with their attending doctor to confirm whether the drug ingredients, specifications and usage match their own treatment plan to avoid medication errors or delays in treatment. In short, whether they choose domestic original drugs or foreign generic drugs, patients should make reasonable choices based on their economic capabilities and medical insurance policies while ensuring drug quality and their own safety.

Reference materials:https://www.drugs.com/